Ocular Therapeutix Long Term Deferred Charges (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

7.78 +0.75 (+10.67%) USD | NASDAQ | Feb 20, 16:00

7.68 -0.10 (-1.29%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Boston Scientific Corp.	--
Alnylam Pharmaceuticals, Inc.	--
EyePoint Plc	--
Vertex Pharmaceuticals, Inc.	--